• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用同基因人类诱导多能干细胞对与骨髓增生异常综合征相关的染色体缺失进行功能分析。

Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.

作者信息

Kotini Andriana G, Chang Chan-Jung, Boussaad Ibrahim, Delrow Jeffrey J, Dolezal Emily K, Nagulapally Abhinav B, Perna Fabiana, Fishbein Gregory A, Klimek Virginia M, Hawkins R David, Huangfu Danwei, Murry Charles E, Graubert Timothy, Nimer Stephen D, Papapetrou Eirini P

机构信息

1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

1] Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA. [2] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.

出版信息

Nat Biotechnol. 2015 Jun;33(6):646-55. doi: 10.1038/nbt.3178. Epub 2015 Mar 23.

DOI:10.1038/nbt.3178
PMID:25798938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4464949/
Abstract

Chromosomal deletions associated with human diseases, such as cancer, are common, but synteny issues complicate modeling of these deletions in mice. We use cellular reprogramming and genome engineering to functionally dissect the loss of chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the del(7q) iPSCs recapitulate disease-associated phenotypes, including impaired hematopoietic differentiation. These disease phenotypes are rescued by spontaneous dosage correction and can be reproduced in karyotypically normal cells by engineering hemizygosity of defined chr7q segments in a 20-Mb region. We use a phenotype-rescue screen to identify candidate haploinsufficient genes that might mediate the del(7q)- hematopoietic defect. Our approach highlights the utility of human iPSCs both for functional mapping of disease-associated large-scale chromosomal deletions and for discovery of haploinsufficient genes.

摘要

与人类疾病(如癌症)相关的染色体缺失很常见,但同线性问题使在小鼠中对这些缺失进行建模变得复杂。我们利用细胞重编程和基因组工程技术,对7号染色体长臂缺失(del(7q))进行功能剖析,这是骨髓增生异常综合征(MDS)中存在的一种体细胞细胞遗传学异常。我们从MDS患者的造血细胞中获得了del(7q)和同基因核型正常的诱导多能干细胞(iPSC),并表明del(7q) iPSC重现了与疾病相关的表型,包括造血分化受损。这些疾病表型可通过自发的剂量校正得到挽救,并且可以通过在一个20兆碱基区域构建特定7号染色体长臂片段的半合子状态,在核型正常的细胞中重现。我们使用表型挽救筛选来鉴定可能介导del(7q)造血缺陷的单倍剂量不足候选基因。我们的方法突出了人类iPSC在疾病相关大规模染色体缺失的功能定位以及单倍剂量不足基因发现方面的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/c1dc9ec2fa8d/nihms664590f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/8657435e2cb9/nihms664590f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/343282215850/nihms664590f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/634e2727cbd5/nihms664590f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/db22aebbabaf/nihms664590f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/e086140cfb58/nihms664590f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/c1dc9ec2fa8d/nihms664590f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/8657435e2cb9/nihms664590f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/343282215850/nihms664590f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/634e2727cbd5/nihms664590f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/db22aebbabaf/nihms664590f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/e086140cfb58/nihms664590f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f555/4464949/c1dc9ec2fa8d/nihms664590f6.jpg

相似文献

1
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.利用同基因人类诱导多能干细胞对与骨髓增生异常综合征相关的染色体缺失进行功能分析。
Nat Biotechnol. 2015 Jun;33(6):646-55. doi: 10.1038/nbt.3178. Epub 2015 Mar 23.
2
Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.使用多能干细胞治疗骨髓衰竭伴 MDS 倾向的治疗发现。
JCI Insight. 2019 Apr 30;5(12):125157. doi: 10.1172/jci.insight.125157.
3
Engineering of targeted megabase-scale deletions in human induced pluripotent stem cells.靶向人诱导多能干细胞中兆碱基规模缺失的工程设计。
Exp Hematol. 2020 Jul;87:25-32. doi: 10.1016/j.exphem.2020.06.001. Epub 2020 Jun 13.
4
Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).通过荧光原位杂交(FISH)对7号染色体长臂(7q)缺失进行分类并鉴定隐匿性易位。
Leukemia. 1996 Apr;10(4):644-9.
5
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.染色体 7q 缺失对接受异基因造血干细胞移植治疗的骨髓增生异常综合征患者结局的临床影响。
Bone Marrow Transplant. 2019 Sep;54(9):1471-1481. doi: 10.1038/s41409-019-0469-5. Epub 2019 Feb 4.
6
The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.伴有 der(1;7)(q10;p10) 的骨髓增生异常综合征具有独特的 -7/del(7q) 缺失谱:系统评价和荟萃分析。
Cancer Med. 2024 Jan;13(1):e6890. doi: 10.1002/cam4.6890. Epub 2024 Jan 1.
7
Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.骨髓增生异常综合征患者的传统及分子细胞遗传学研究结果
Clin Exp Med. 2005 Jul;5(2):55-9. doi: 10.1007/s10238-005-0066-3.
8
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.骨髓增生异常综合征患者存在 del(7q) 的预后优于单纯 7 号染色体单体的患者。
Cancer. 2012 Jan 1;118(1):127-33. doi: 10.1002/cncr.26279. Epub 2011 Jun 29.
9
Cytogenetic abnormalities in myelodysplastic syndrome: an overview.骨髓增生异常综合征的细胞遗传学异常:综述
Hematology. 2011 May;16(3):131-8. doi: 10.1179/102453311X12940641877966.
10
Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.孤立性部分或全部 7 号染色体缺失的骨髓增生异常患者体细胞突变的影响。
Leukemia. 2020 Sep;34(9):2441-2450. doi: 10.1038/s41375-020-0728-x. Epub 2020 Feb 17.

引用本文的文献

1
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.RNA错配剪接的SF3B1突变模型揭示UBA1作为骨髓增生异常肿瘤的治疗靶点。
Leukemia. 2025 Aug 26. doi: 10.1038/s41375-025-02740-1.
2
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression.在RUNX1和SRSF2突变背景下,破坏bZIP结构域的杂合CEBPA突变会导致骨髓增生异常综合征疾病进展。
Nat Commun. 2025 Jul 1;16(1):5489. doi: 10.1038/s41467-025-60192-8.
3
Multiplex gene editing models of del(7q) reveal combined and loss drives clonal expansion and drug resistance.

本文引用的文献

1
An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.一种用于在人类多能干细胞中进行快速、多重且可诱导的基因组编辑的iCRISPR平台。
Cell Stem Cell. 2014 Aug 7;15(2):215-226. doi: 10.1016/j.stem.2014.05.018. Epub 2014 Jun 12.
2
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.MLL3 是急性髓系白血病中具有杂合性缺失的 7q 肿瘤抑制因子。
Cancer Cell. 2014 May 12;25(5):652-65. doi: 10.1016/j.ccr.2014.03.016. Epub 2014 May 1.
3
Recurrent genetic defects on chromosome 7q in myeloid neoplasms.
7号染色体长臂缺失(del(7q))的多重基因编辑模型揭示,联合缺失和功能丧失驱动克隆性扩增和耐药性。
Blood Neoplasia. 2025 Mar 3;2(2):100083. doi: 10.1016/j.bneo.2025.100083. eCollection 2025 May.
4
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions.伴有7号染色体缺失的急性髓系白血病从诊断到复发的突变动态变化
Leuk Lymphoma. 2025 Jul;66(7):1221-1233. doi: 10.1080/10428194.2025.2477723. Epub 2025 Mar 31.
5
Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer.在一种基于人诱导多能干细胞的新型乳腺癌模型中研究患者对PARP抑制剂的特异性反应。
NPJ Precis Oncol. 2025 Feb 25;9(1):53. doi: 10.1038/s41698-025-00837-5.
6
LUC7 proteins define two major classes of 5' splice sites in animals and plants.LUC7蛋白在动物和植物中定义了两类主要的5'剪接位点。
Nat Commun. 2025 Feb 20;16(1):1574. doi: 10.1038/s41467-025-56577-4.
7
Decoding cancer etiology with cellular reprogramming.利用细胞重编程解码癌症病因。
Curr Opin Genet Dev. 2025 Feb;90:102301. doi: 10.1016/j.gde.2024.102301. Epub 2024 Dec 24.
8
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development.白血病发展过程中克隆进化、分化层次和个体发生的交叉点
Blood Cancer Discov. 2025 Mar 4;6(2):94-109. doi: 10.1158/2643-3230.BCD-24-0235.
9
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.RAS 突变型白血病干细胞导致对维奈克拉的临床耐药。
Nature. 2024 Dec;636(8041):241-250. doi: 10.1038/s41586-024-08137-x. Epub 2024 Oct 30.
10
CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells.CRISPR 依赖谱分析在原代造血干细胞中发现 KDM3B 是 IDH2 和 TET2 突变细胞中基因型特异性脆弱性的关键。
Cancer Discov. 2024 Oct 4;14(10):1860-1878. doi: 10.1158/2159-8290.CD-23-1092.
髓系肿瘤中7号染色体长臂上的复发性基因缺陷。
Leukemia. 2014 Jun;28(6):1348-51. doi: 10.1038/leu.2014.25. Epub 2014 Jan 16.
4
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.累积的单倍体不足和三倍体敏感性驱动非整倍体模式,并塑造癌症基因组。
Cell. 2013 Nov 7;155(4):948-62. doi: 10.1016/j.cell.2013.10.011. Epub 2013 Oct 31.
5
The biology and clinical impact of genetic lesions in myeloid malignancies.髓系恶性肿瘤中遗传病变的生物学和临床影响。
Blood. 2013 Nov 28;122(23):3741-8. doi: 10.1182/blood-2013-06-460295. Epub 2013 Aug 16.
6
Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.全基因组敲除小鼠的生成和系统表型分析揭示了许多基因的新作用。
Cell. 2013 Jul 18;154(2):452-64. doi: 10.1016/j.cell.2013.06.022.
7
Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies.位于7号染色体长臂34区的假定RNA剪接基因LUC7L2是髓系恶性肿瘤发病机制中的一个候选基因。
Blood Cancer J. 2013 May 24;3(5):e117. doi: 10.1038/bcj.2013.16.
8
Defining the path to hematopoietic stem cells.确定通向造血干细胞的途径。
Nat Biotechnol. 2013 May;31(5):416-8. doi: 10.1038/nbt.2571.
9
Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia.核糖体蛋白 SA 单倍体不足导致人类孤立性先天性脾缺如。
Science. 2013 May 24;340(6135):976-8. doi: 10.1126/science.1234864. Epub 2013 Apr 11.
10
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.检测不纯和异质癌症样本中的体细胞点突变。
Nat Biotechnol. 2013 Mar;31(3):213-9. doi: 10.1038/nbt.2514. Epub 2013 Feb 10.